Results 11 to 20 of about 3,973,140 (195)

Older Adults in Psychedelic-Assisted Therapy Trials: A Systematic Review [PDF]

open access: yesEur Psychiatry
IntroductionGrowing clinical interest in psychedelic-assisted therapies has led to a second wave of research involving psilocybin, LSD, MDMA and other substances. Data suggests that these compounds have the potential to treat mental health conditions that are especially prevalent in older adults such as depression, anxiety, existential distress and ...
Bouchet L   +7 more
europepmc   +6 more sources

Psychedelic-Assisted Group Therapy: A Systematic Review [PDF]

open access: yesJournal of Psychoactive Drugs, 2019
Contemporary research with classic psychedelic drugs (e.g., lysergic acid diethylamide (LSD) and psilocybin) is indebted to the twentieth-century researchers and clinicians who generated valuable clinical knowledge of these substances through experimentation.
Brian T Anderson   +2 more
exaly   +7 more sources

How to Make Psychedelic-Assisted Therapy Safer [PDF]

open access: yesCambridge Quarterly of Healthcare Ethics
Abstract Classic serotonergic psychedelics are experiencing a clinical revival, which has also revived ethical debates about psychedelic-assisted therapy. A particular issue here is how to prepare and protect patients from the vulnerability that the psychedelic state creates.
Daniel Villiger
exaly   +5 more sources

CE: Psychedelic-Assisted Therapy [PDF]

open access: yesAJN, American Journal of Nursing, 2021
ABSTRACT: Psychedelics are a class of psychoactive substances that were studied extensively between 1943 and 1970 as potential therapies for treating a host of mental health disorders, including addiction. Despite promising early results, U.S.
Penn, Andrew   +3 more
openaire   +5 more sources

A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development

open access: yesFrontiers in Psychiatry, 2021
Psychedelic-assisted therapy research for depression and PTSD has been fast tracked in the United States with the Food and Drugs Administration (FDA) granting breakthrough designations for MDMA (post-traumatic stress disorder) and psilocybin (major ...
Henry J. Whitfield   +2 more
doaj   +2 more sources

Mechanisms of integration in psychedelic-assisted therapy. [PDF]

open access: yesJ Mil Veteran Fam Health, 2023
LAY SUMMARY Psychedelic pharmacotherapies combined with structured psychotherapy have shown promise in the treatment of several psychological conditions. This type of therapy is known as psychedelic-assisted psychotherapy (PAP) and includes three phases: preparation, in-session support, and integration.
Coverdale NS, Cook DJ.
europepmc   +3 more sources

Oncology Providers' Perspectives on Psychedelic-Assisted Therapy. [PDF]

open access: yesAm J Hosp Palliat Care
Purpose Despite most psychedelic substances remaining Schedule I, clinical research exploring psychedelic-assisted therapy (PAT) in oncology is expanding. We sought to assess oncology providers’ attitudes toward and understanding of PAT. Methods
Hanubal KS   +8 more
europepmc   +3 more sources

Not a Standalone Treatment: Considerations for Psychedelic-Assisted Therapy. [PDF]

open access: yesBrain Behav
ABSTRACT Purpose Psychedelic‐assisted therapy (PAT) is becoming a clinically available treatment for patients with treatment‐resistant conditions such as depression and post‐traumatic stress disorder (PTSD) in several countries.
Murphy S   +5 more
europepmc   +4 more sources

Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program. [PDF]

open access: yesNeurosci Appl
This article describes the Swiss limited access program for psychedelic/3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy. The Swiss Federal Office of Public Health can issue authorizations for the limited medical use of otherwise prohibited ...
Liechti ME   +5 more
europepmc   +3 more sources

Home - About - Disclaimer - Privacy